The Candida Infections Drugs market was valued at USD 14.42 Billion in 2021 and is expected to reach USD 19.73 Billion by 2029, growing at a CAGR of 4% (2021-2029). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.